EUVIMEDEUVIMED entdecken
Crossref

Interventional Study of Flunarizine Therapy on Symptom Relief and Vestibular Evoked Myogenic Potential Changes in Individuals with Vestibular Migraine

Farnaz Nasrin Islam, Kaushlendra Kumar, Meera Niranjan Khadilkar, Anupriya Ebenezer, Deviprasad Dosemane

Audiology and Neurotology · 2023 · 28 (5) · 338-343

DOI: 10.1159/000530740 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Audiology and Neurotology, online erschienen am 20.06.2023. Verfasst von Farnaz Nasrin Islam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology and Head & Neck Surgery, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India. Hauptthemen laut MEDLINE: Vestibular Evoked Myogenic Potentials, Migraine Disorders. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Migraine is the third most common disease in the world with an estimated prevalence of 14.7%. The purpose of this study was to identify the characteristic changes in cervical and ocular vestibular evoked myogenic potential (VEMP) and analyse changes in symptoms and VEMP after flunarizine therapy in patients diagnosed with vestibular migraine (VM).

Methods

Prospective interventional study was conducted on 31 VM patients. Cervical VEMP (cVEMP) and ocular VEMP (oVEMP) were recorded. Flunarizine (10 mg) was given once daily for two consecutive months. Prophylactic therapy was monitored with a monthly follow-up assessment of their symptoms and VEMP was repeated after 2 months.

Results

Headache was the chief complaint (67.7%). Vertigo was spontaneous and mostly moderate in intensity (93%). cVEMP was absent in 1 patient and oVEMP was absent in 3 patients. Post prophylactic treatment with flunarizine, there was significant reduction in the frequency (p = 0.001) and duration (p = 0.001) of headache and frequency (p = 0.001), duration (p = 0.001), and intensity (p = 0.009) of vertigo. cVEMP and oVEMP showed no significant differences (p > 0.05) between pre- and post-treatment recordings.

Conclusion

Treatment with flunarizine helps in considerably reducing the episodes and duration of headache, as well as episodes, duration, and intensity of vertigo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vestibular Evoked Myogenic PotentialsMigraine DisordersHumansFlunarizineProspective StudiesVertigoHeadache

Stichwörter der Autor:innen

FlunarizineHeadacheMigraineVertigoVestibular diseasesVestibular evoked myogenic potentials

Substanzen

Flunarizine

Autor:innen und Institutionen

  • Department of Otorhinolaryngology and Head & Neck Surgery, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India.
  • Department of Audiology and Speech Language Pathology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India.

Zitieren

APA

Islam, F. N., Kumar, K., Khadilkar, M. N., Ebenezer, A., & Dosemane, D. (2023). Interventional Study of Flunarizine Therapy on Symptom Relief and Vestibular Evoked Myogenic Potential Changes in Individuals with Vestibular Migraine. Audiology and Neurotology, 28(5), 338-343. https://doi.org/10.1159/000530740

Vancouver

Islam FN, Kumar K, Khadilkar MN, Ebenezer A, Dosemane D. Interventional Study of Flunarizine Therapy on Symptom Relief and Vestibular Evoked Myogenic Potential Changes in Individuals with Vestibular Migraine. Audiology and Neurotology. 2023;28(5):338-343. doi:10.1159/000530740

BibTeX
@article{Islam2023,
  author = {Islam, Farnaz Nasrin and Kumar, Kaushlendra and Khadilkar, Meera Niranjan and Ebenezer, Anupriya and Dosemane, Deviprasad},
  title = {Interventional Study of Flunarizine Therapy on Symptom Relief and Vestibular Evoked Myogenic Potential Changes in Individuals with Vestibular Migraine},
  journal = {Audiology and Neurotology},
  year = {2023},
  volume = {28},
  number = {5},
  pages = {338--343},
  doi = {10.1159/000530740}
}
Kostenlos starten →